769 (Topiramate Extended-Release 100 mg)
Pill with imprint 769 is White, Capsule-shape and has been identified as Topiramate Extended-Release 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 769
- 100 mg
- 23.00 mm
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Cadila Healthcare Limited
- National Drug Code (NDC)
- Inactive Ingredients
alcohol, ammonia, butyl alcohol, microcrystalline cellulose, ethylcelluloses, ferrosoferric oxide, gelatin, hydrogenated castor oil, hypromelloses, isopropyl alcohol, polyethylene glycol, potassium hydroxide, povidone, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, water
Note: Inactive ingredients may vary.
Related Images for "769"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1080 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Sprinkle Capsules
- Topiramate (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.